BIOMAT Database Logo BIOMAT Database Logo

Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. 1978

E J Goldstein, and V L Sutter, and S M Finegold

The susceptibilities of 284 anaerobic bacteria, including 55 strains of the Bacteroides fragilis group, were determined by an agar dilution technique to metronidazole and two newer nitroimidazoles, ornidazole and SC-28538. All three agents showed marked in vitro activity against virtually all anaerobic bacteria tested. At concentrations </=1 mug/ml, SC-28538 was significantly more active than either metronidazole or ornidazole. At concentrations of >1 mug/ml, the activities of all three agents were comparable. Propionibacterium and Actinomyces showed significant resistance to all three agents. Anaerobic and microaerophilic members of the genus Streptococcus were also often resistant, in contrast to Peptococcus and Peptostreptococcus strains. In addition, the bactericidal activities of ornidazole and SC-28538 were determined against 27 strains of the B. fragilis group by a broth dilution technique. The minimal inhibitory and minimal bactericidal concentrations of each agent were very close. At concentrations of </=0.5 mug/ml, SC-28538 showed greater bactericidal activity; at concentrations of >/=2 mug/ml, the activies of both agents were similar.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D009950 Ornidazole A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action. Ro 7-0207,Ro-70207,Ro7-0207,Tiberal,Ro 7 0207,Ro 70207,Ro7 0207,Ro70207
D000693 Anaerobiosis The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Anaerobic Metabolism,Anaerobic Metabolisms,Anaerobioses,Metabolism, Anaerobic,Metabolisms, Anaerobic
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

E J Goldstein, and V L Sutter, and S M Finegold
[Comparative study, using 3 methods, of the sensitivity to metronidazole and ornidazole of anaerobic or related bacteria].
January 1983, Annales de microbiologie,
E J Goldstein, and V L Sutter, and S M Finegold
Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.
April 1977, Antimicrobial agents and chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
Comparative pharmacokinetic studies of ornidazole and metronidazole in man.
January 1976, Chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
April 1977, Antimicrobial agents and chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
April 1983, Antimicrobial agents and chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
In vitro susceptibilities of anaerobic bacteria to josamycin.
May 1976, Antimicrobial agents and chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics.
June 1980, Antimicrobial agents and chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
August 1993, Antimicrobial agents and chemotherapy,
E J Goldstein, and V L Sutter, and S M Finegold
["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
January 1980, Annales de microbiologie,
E J Goldstein, and V L Sutter, and S M Finegold
[Comparative therapeutic trial of ornidazole and metronidazole in chronic amebiasis].
January 1977, Revista do Instituto de Medicina Tropical de Sao Paulo,
Copied contents to your clipboard!